These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 28711882)

  • 41. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis.
    Gono T; Kawaguchi Y; Satoh T; Kuwana M; Katsumata Y; Takagi K; Masuda I; Tochimoto A; Baba S; Okamoto Y; Ota Y; Yamanaka H
    Rheumatology (Oxford); 2010 Sep; 49(9):1713-9. PubMed ID: 20498012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis/dermatomyositis in Chinese Han population.
    Chen S; Wang Q; Wu Z; Li Y; Li P; Sun F; Zheng W; Wu Q; Wu C; Deng C; Zhang F; Li Y
    PLoS One; 2014; 9(10):e110044. PubMed ID: 25337792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients.
    Paradowska-Gorycka A; Stypińska B; Olesińska M; Felis-Giemza A; Mańczak M; Czuszynska Z; Zdrojewski Z; Wojciechowicz J; Jurkowska M
    HLA; 2016 Jan; 87(1):13-8. PubMed ID: 26818120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surfactant protein D is associated with 3-month mortality of anti-MDA5 antibody-interstitial lung disease.
    Lyu W; Zhou Y; Zhuang Y; Liu Y; Cao M; Xin X; Wu H; Wang J; Meng F; Cai H; Dai J
    Clin Exp Rheumatol; 2020; 38(6):1068-1074. PubMed ID: 31994487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease.
    Nishina N; Sato S; Masui K; Gono T; Kuwana M
    RMD Open; 2020 Jun; 6(2):. PubMed ID: 32506053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy.
    Abe Y; Kusaoi M; Tada K; Yamaji K; Tamura N
    Rheumatology (Oxford); 2020 Apr; 59(4):767-771. PubMed ID: 31504956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic evaluation of serum osteopontin in patients with anti-MDA5 antibody-positive dermatomyositis associated interstitial lung disease.
    Gao Y; Zhao Q; Xie M; Yan X; Li Y; Zhang X; Wu H; Dai J; Cao M; Cai H
    Cytokine; 2020 Nov; 135():155209. PubMed ID: 32738770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease.
    Ren FP; Chen Q; Yao SS; Feng L; Xue XY; Zhao WC; Wang D; Zhao ZL; Gu SW; Li T; Shen YW; Gao L; Zang XL; Bao XY; Tong ZH
    BMC Pulm Med; 2023 Oct; 23(1):411. PubMed ID: 37898737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody.
    Kishaba T; McGill R; Nei Y; Ibuki S; Momose M; Nishiyama K; Nagano H; Yamashiro S
    J Med Invest; 2018; 65(3.4):251-257. PubMed ID: 30282869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Case of Dermatomyositis with Severe Myalgia and Muscle Weakness Testing Positive for Anti-melanoma Differentiation-associated Gene 5 Antibody.
    Yamazaki K; Wakabayashi H; Suganami Y; Sano S; Wakunami Y; Katayama T; Deguchi K; Nagotani S; Kishida M
    Acta Med Okayama; 2017 Aug; 71(4):341-344. PubMed ID: 28824190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic change of lymphocytes associated with short-term prognosis in anti-MDA5-positive dermatomyositis with interstitial lung disease: a multicenter retrospective study.
    Tian Y; He P; Ren L; Xin H; Xi B; Zou R; Zhao Q; Yan X; Qiu X; Gao Y; Liu Y; Cao M; Jiang H; Chen B; Chen J; Cai H
    Clin Rheumatol; 2024 Nov; 43(11):3399-3408. PubMed ID: 39292419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody.
    Hosono Y; Nakashima R; Serada S; Murakami K; Imura Y; Yoshifuji H; Ohmura K; Naka T; Mimori T
    J Autoimmun; 2017 Feb; 77():116-122. PubMed ID: 27919567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum.
    Yashiro M; Asano T; Sato S; Kobayashi H; Watanabe H; Miyata M; Migita K
    Fukushima J Med Sci; 2018; 64(2):89-94. PubMed ID: 30158335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical characteristics of subcutaneous and mediastinal emphysema in anti-melanoma differentiation-associated 5 positive dermatomyositis associated with interstitial lung disease.
    Huang W; Chen D; Ren F; Luo L; Zhou J; Huang D; Tian M; Qian K; Jiang Y; Tang L
    Clin Exp Rheumatol; 2024 Feb; 42(2):262-268. PubMed ID: 38147317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients.
    Ono N; Kai K; Maruyama A; Sakai M; Sadanaga Y; Koarada S; Inoue T; Tada Y
    Rheumatology (Oxford); 2019 May; 58(5):786-791. PubMed ID: 30541137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis.
    Xing X; Li A; Li C
    Respir Med; 2020 Oct; 172():106134. PubMed ID: 32905890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positive Association between
    Li L; Chen S; Wen X; Wang Q; Lv G; Li J; Yang F; Zhang F; Li Y
    Biomed Res Int; 2017; 2017():2905987. PubMed ID: 28470010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
    Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
    Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical features of thirty-two patients with anti-melanoma differentiation-associated gene 5 antibodies.
    Huang W; Ren F; Wang Q; Luo L; Zhou J; Huang D; Pan Z; Tang L
    Clin Exp Rheumatol; 2019; 37(5):803-807. PubMed ID: 30767866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age.
    Yamaguchi K; Yamaguchi A; Onuki Y; Itai M; Kashiwagi C; Takehara K; Aoki S; Kanaya A; Taguchi K; Umetsu K; Oshima K; Uchida M; Kimura H; Kasahara M; Takemura M; Hara K; Sekiguchi A; Motegi SI; Muro Y; Nakasatomi M; Motohashi R; Sakairi T; Nakagawa J; Hiromura K; Obokata M; Kurabayashi M; Maeno T
    Mod Rheumatol; 2021 Jan; 31(1):177-185. PubMed ID: 32149542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.